sweroside has been researched along with Osteoporosis, Postmenopausal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, Y; Kim, MH; Yang, WM | 1 |
| Ding, Y; Jiang, H; Meng, B; Xiang, G; Yu, X; Zhu, B | 1 |
2 other study(ies) available for sweroside and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Promotion of osteogenesis by Sweroside via BMP2-involved signaling in postmenopausal osteoporosis.
Topics: Animals; Bone Morphogenetic Protein 2; Cell Differentiation; Disease Models, Animal; Female; Humans; Iridoid Glucosides; Mice; Osteoblasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Seminal Vesicle Secretory Proteins; Signal Transduction | 2021 |
Sweroside-mediated mTORC1 hyperactivation in bone marrow mesenchymal stem cells promotes osteogenic differentiation.
Topics: Animals; Biomarkers; Cell Differentiation; Core Binding Factor Alpha 1 Subunit; Disease Models, Animal; Drug Administration Schedule; Female; Humans; Iridoid Glucosides; Mechanistic Target of Rapamycin Complex 1; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Osteocalcin; Osteoporosis, Postmenopausal; Signal Transduction; Sp7 Transcription Factor; X-Ray Microtomography | 2019 |